Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
LATEST IN amyloid-β protein
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Eye on UMSL: Primed to lead
The PRIMED Institute in Character Education’s annual five-day event held on UMSL’s campus is designed for school leaders committed to fostering character development in students.
CLIMB program celebrates 10th class of summer interns
A total of four students from Hazelwood East High School, Hazelwood West High School and University City High School took part in the paid summer internship program.
CLIMB program celebrates 10th class of summer interns
A total of four students from Hazelwood East High School, Hazelwood West High School and University City High School took part in the paid summer internship program.
CLIMB program celebrates 10th class of summer interns
A total of four students from Hazelwood East High School, Hazelwood West High School and University City High School took part in the paid summer internship program.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
MORE IN amyloid-β protein
LATEST NEWS
- Eye on UMSL: Primed to lead
- Master’s grad Shiori Kaji has audit accounting role lined up with Anders CPA
- Geospatial summer camp offers high schoolers hands-on experience with emerging technology
- Fourth-year Optometry student Emerald Jones honored as recipient of prestigious Remington R. Williams Award
- Chemistry Professor Michael Nichols discusses Alzheimer’s disease research in latest episode of Inside UMSL podcast
- Inaugural UMSL Engineering Camp helps high school students build excitement about the field
- UMSL names College of Business after accomplished alum and marketing industry leader Ed G. Smith
- College of Education hosts annual Future Teacher Leadership Academy for local high schoolers
- Eye on UMSL: For a good cause
- Art and Design Professor Jeff Sippel named Missouri Arts Council’s Featured Artist for June 2025
